BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36208717)

  • 1. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
    Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
    J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous.
    Tammemägi MC; Cina K; Kitts AKB; Koop D; Petereit MA; Sargent M; Petereit DG
    Cancer; 2023 Dec; 129(24):3894-3904. PubMed ID: 37807694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
    Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP
    Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking.
    Li CC; Matthews AK; Rywant MM; Hallgren E; Shah RC
    Cancer Causes Control; 2019 Mar; 30(3):235-240. PubMed ID: 30377905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
    Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
    Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
    Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
    JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
    Hüsing A; Kaaks R
    Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review.
    Williams RM; Kareff SA; Sackstein P; Roy T; Luta G; Kim C; Taylor KL; Tammemägi MC
    Lung Cancer; 2022 Jul; 169():55-60. PubMed ID: 35644087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
    Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
    Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
    Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
    Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
    Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
    JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of Chronic Smoking Behavior and Eligibility for Low-Dose Computed Tomography for Lung Cancer Screening Among Older Chinese Male Smokers.
    Li CC; Matthews AK; Dong X
    J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(suppl_1):S22-S25. PubMed ID: 28575258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates.
    Pinsky PF; Lau YK; Doubeni CA
    Chest; 2021 Jul; 160(1):341-350. PubMed ID: 33545164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: Risk Prediction Model Versus United States Preventive Services Task Force 2020 Draft Lung Cancer Screening Eligibility Criteria-Reducing Race Disparities.
    Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
    JTO Clin Res Rep; 2021 Mar; 2(3):100137. PubMed ID: 34590000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
    Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
    Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
    Silvestri GA; Goldman L; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Tanner NT; Fedewa S
    Ann Intern Med; 2022 Nov; 175(11):1501-1505. PubMed ID: 36215712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
    Wu GX; Goldstein L; Kim JY; Raz DJ
    Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the revised LDCT lung cancer screening guideline bridge the racial disparities gap: Results from the health and retirement study.
    Li CC; Manella J; Kefi SE; Matthews AK
    J Natl Med Assoc; 2024 Apr; 116(2 Pt 1):180-188. PubMed ID: 38245469
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.